Petter Olsson

1.7k total citations
58 papers, 1.2k citations indexed

About

Petter Olsson is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, Petter Olsson has authored 58 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 21 papers in Physiology and 17 papers in Immunology and Allergy. Recurrent topics in Petter Olsson's work include Asthma and respiratory diseases (21 papers), Allergic Rhinitis and Sensitization (17 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers). Petter Olsson is often cited by papers focused on Asthma and respiratory diseases (21 papers), Allergic Rhinitis and Sensitization (17 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers). Petter Olsson collaborates with scholars based in Sweden, Switzerland and United States. Petter Olsson's co-authors include Pär Stjärne, Björn Ställberg, Bengt G. Herslöf, Jadwiga A. Wedzicha, Tom Bellander, Thommy Ekström, Niklas Berglind, Steven Nordin, Abolfazl Asadi and Anders Jacobsson and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Neuroscience and Journal of Allergy and Clinical Immunology.

In The Last Decade

Petter Olsson

56 papers receiving 1.2k citations

Peers

Countries citing papers authored by Petter Olsson

Since Specialization

Citations

This map shows the geographic impact of Petter Olsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petter Olsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petter Olsson more than expected).

Fields of papers citing papers by Petter Olsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petter Olsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petter Olsson. The network helps show where Petter Olsson may publish in the future.

Co-authorship network of co-authors of Petter Olsson

This figure shows the co-authorship network connecting the top 25 collaborators of Petter Olsson. A scholar is included among the top collaborators of Petter Olsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petter Olsson. Petter Olsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Complications and Economic Burden of Surgery in Chronic Rhinosinusitis With Nasal Polyps: An Observational Cohort Study Using Swedish Register Data 2025 ·Clinical Otolaryngology ·Petter Olsson, Christoph Abé, Maija Wolf, (unknown), (unknown), Ola Sunnergren, P. Sahlstrand-Johnson	1
2	Clinical characteristics and 6-month follow-up of adults with and without alcohol use disorder who self-harm 2024 ·Frontiers in Psychiatry ·Petter Olsson, Stefan Wiktorsson, (unknown), Ellinor Salander Renberg, Bo Runeson, Margda Wærn	0
3	Attention deficit hyperactivity disorder in adults who present with self-harm: a comparative 6-month follow-up study 2022 ·BMC Psychiatry ·Petter Olsson, Stefan Wiktorsson, (unknown), Ellinor Salander Renberg, Bo Runeson, Margda Wærn	12
4	The Role of Omalizumab in NSAID-Exacerbated Respiratory Disease: A Narrative Review 2022 ·The Journal of Allergy and Clinical Immunology In Practice ·Masami Taniguchi, Enrico Heffler, Heidi Olze, Andrew A. White, (unknown), Petter Olsson, (unknown)	8
5	Omalizumab is associated with a reduced need for surgery in patients with nasal polyposis 2020 ·Allergy ·Philippe Gevaert, Peter W. Hellings, (unknown), J. Mullol, Randall A. Ow, Petter Olsson, Rui Zhao, (unknown), Lutaf Islam, Theodore A. Omachi	1
6	Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial 2017 ·American Journal of Respiratory and Critical Care Medicine ·Nicolás Roche, Kenneth R. Chapman, Claus Vogelmeier, Felix Herth, Chau Thach, Robert Fogel, Petter Olsson, Francesco Patalano, Donald Banerji, Jadwiga A. Wedzicha	116
7	Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population 2017 ·Respiratory Research ·Leif Bjermer, Job F. M. van Boven, Madlaina Costa‐Scharplatz, Dorothy L. Keininger, F Gutzwiller, Karin Lisspers, (unknown), Petter Olsson, Nicolás Roche	4
8	Once-daily QVA149 improves dyspnoea, lung function and reduces rescue medication use in symptomatic patients with COPD using LAMA as prior medication: The BLAZE study 2014 ·European Respiratory Journal ·Anthony D’Urzo, Donald A. Mahler, Petter Olsson, Hungta Chen, Robert Fogel, Donald Banerji	2
9	Effect of QVA149 on lung function in the subgroup of patients with a history of exacerbations in the previous year and baseline ICS use from the SHINE study 2014 ·European Respiratory Journal ·Kenneth R. Chapman, Eric Bateman, Petter Olsson, Hungta Chen, Donald Banerji, Robert Fogel	1
10	Elovl2 ablation demonstrates that systemic DHA is endogenously produced and is essential for lipid homeostasis in mice 2014 ·Journal of Lipid Research ·(unknown), Petter Olsson, Abolfazl Asadi, Bengt G. Herslöf, Robert I. Csikasz, Damir Zadravec, Anders Jacobsson	102
11	Class separation of lipids and polycyclic aromatic hydrocarbons in normal phase high performance liquid chromatography – A prospect for analysis of aromatics in edible vegetable oils and biodiesel exhaust particulates 2014 ·Journal of Chromatography A ·Petter Olsson, Ioannis Sadiktsis, (unknown), Roger Westerholm	16
12	A single step reversed-phase high performance liquid chromatography separation of polar and non-polar lipids 2014 ·Journal of Chromatography A ·Petter Olsson, (unknown), Bengt G. Herslöf	8
13	Cost-effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis 2012 ·Primary Care Respiratory Journal ·Johanna Svensson, (unknown), Petter Olsson, Pär Stjärne, Gunnel Ragnarson Tennvall	4
14	High costs and burden of illness in acute rhinosinusitis: real-life treatment patterns and outcomes in Swedish primary care 2012 ·Primary Care Respiratory Journal ·Pär Stjärne, (unknown), Björn Ställberg, (unknown), Petter Olsson	25
15	Effects of smell loss on daily life and adopted coping strategies in patients with nasal polyposis with asthma 2011 ·Acta Oto-Laryngologica ·Steven Nordin, Ebba Hedén Blomqvist, Petter Olsson, Pär Stjärne, (unknown), (unknown)	61
16	Use of Mometasone Furoate to Prevent Polyp Relapse After Endoscopic Sinus Surgery 2009 ·Archives of Otolaryngology - Head and Neck Surgery ·Pär Stjärne, Petter Olsson, (unknown)	74
17	A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma 2008 ·Respiratory Medicine ·Björn Ställberg, Thommy Ekström, (unknown), Petter Olsson, (unknown), Göran Wennergren, (unknown)	26
18	Comparable morning versus evening administration of once-daily mometasone furoate dry powder inhaler 2008 ·Respiratory Medicine ·O. Zetterström, Ronald Dahl, Ari Lindqvist, Petter Olsson	10
19	Living with asthma in Sweden—the ALMA study 2003 ·Respiratory Medicine ·(unknown), (unknown), Petter Olsson, (unknown), Eva Rönmark, Bo Lundbäck	15
20	Extracorporeal CO2-removal with a heparin coated artificial lung 1988 ·Intensive Care Medicine ·Jeroen Peters, Peter Radermacher, (unknown), (unknown), (unknown), Karl‐Friedrich Bürrig, Hans‐Bernd Hopf, Rolf Rossaint, H. D. Schulte, Petter Olsson, K. J. Falke	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact